Ipsen Innovation

Neurology and Movement Disorders

Clinical research includes cervical dystonia, with attention to symptom control and functional improvement in adults affected by involuntary muscle contractions.

  • Cervical dystonia
  • Botulinum toxin-based therapy

Trials in this area reflect interest in neurological conditions involving abnormal muscle activity and impaired motor control.

Headache and Migraine Disorders

The sponsor is active in studies of episodic migraine and chronic migraine, with research focused on reducing migraine burden in adult populations.

  • Episodic migraine
  • Chronic migraine

This therapeutic area covers prevention-oriented research for recurrent headache disorders.

Spasticity and Post-Stroke Rehabilitation

Research activity also includes upper limb spasticity after stroke or traumatic brain injury, addressing increased muscle tone and movement limitation in rehabilitation settings.

  • Upper limb spasticity
  • Stroke-related motor impairment

These studies are relevant to acquired neurological injury and associated motor dysfunction.

Aesthetic Medicine and Facial Line Treatment

The sponsor funds research on moderate to severe glabellar lines, forehead lines, and upper facial lines, with a focus on visible facial expression lines in adults.

  • Glabellar lines
  • Forehead lines
  • Upper facial lines

These trials sit within the field of medical aesthetics and facial appearance treatment.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Corabotase for Moderate to Severe Glabellar Lines in Adults

    Recruiting

    3 1
    Investigated diseases:
    France Germany
  • Study on IPN10200 for Treating Cervical Dystonia in Adults

    Recruiting

    2 1
    Czechia France Germany Italy Poland Spain
  • Study on the Safety and Effectiveness of IPN10200 and Botulinum Toxin Type A for Adults with Moderate to Severe Upper Facial Lines

    Recruiting

    2 1 1
    France Germany
  • Study on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury

    Recruiting

    2 1 1
    Austria Bulgaria Czechia France Germany Hungary +4
  • Efficacy and Safety of Maintenance Cabozantinib Plus Best Supportive Care in Pediatric and AYA Patients with Unresectable Residual Osteosarcoma

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Austria Belgium Denmark France Germany Ireland +5
  • Study of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults

    Not recruiting

    2 1
    Czechia France Germany Poland Spain